Related references
Note: Only part of the references are listed.Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-κB Signaling Pathway
Ji-Hyun Lee et al.
DIABETES (2009)
Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol
Lu Gan et al.
HYPERTENSION RESEARCH (2009)
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy
Jeong Hun Kim et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Prevention of Ocular Inflammation in Endotoxin-Induced Uveitis with Resveratrol by Inhibiting Oxidative Damage and Nuclear Factor-κB Activation
Shunsuke Kubota et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Diabetic Retinopathy and Angiogenesis
Talia N. Crawford et al.
CURRENT DIABETES REVIEWS (2009)
The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats
Coskun Silan
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Resveratrol - A multitargeted agent for age-associated chronic diseases
Kuzhuvelil B. Harikumar et al.
CELL CYCLE (2008)
Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases
Hector I. Rocha-Gonzalez et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Protein kinase C-δ mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway
Young-Hee Kim et al.
DIABETES (2008)
Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways
Jen-Ying Deng et al.
DIABETES (2008)
Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas
Xinynan Zhang et al.
DIABETES (2008)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Characterization of azurocidin as a permeability factor in the retina: Involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown
Dimitra Skondra et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Protein kinase C δ regulates anti-apoptotic αB-crystallin in the retina of type 2 diabetes
Y. H. Kim et al.
NEUROBIOLOGY OF DISEASE (2007)
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne et al.
NATURE (2007)
Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy
Ermelindo C. Leal et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Resveratrol - From basic science to the clinic
Valeria Cucciolla et al.
CELL CYCLE (2007)
Impaired apparent ion demand in experimental diabetic retinopathy: Correction by lipoic acid
Bruce A. Berkowitz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakage
Y. H. Kim et al.
LIFE SCIENCES (2007)
SIRT1 activation confers neuroprotection in experimental optic neuritis
Kenneth S. Shindler et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Triamcinolone suppresses retinal interruption of proinflammatory vascular pathology via a potent signal-regulated activation of VEGF during a relative hypoxia
Y. H. Kim et al.
NEUROBIOLOGY OF DISEASE (2007)
Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy
Nami Nishikiori et al.
DIABETES (2007)
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase
Mahesh Thirunavukkarasu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats
Andrea Cignarella et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2006)
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate
DR Valenzano et al.
CURRENT BIOLOGY (2006)
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats
S Sharma et al.
PHARMACOLOGY (2006)
Vascular dysfunction in aging: Potential effects of resveratrol, an anti-inflammatory phytoestrogen
N Labinskyy et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Changes in rhodopsin kinase and transducin in the rat retina in early-stage diabetes
YH Kim et al.
EXPERIMENTAL EYE RESEARCH (2005)
Microvascular basement membranes in diabetes mellitus
EC Tsilibary
JOURNAL OF PATHOLOGY (2003)
Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
VEGF164 is proinflammatory in the diabetic retina
S Ishida et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation
MT Lin et al.
MOLECULAR PHARMACOLOGY (2003)
Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 - Potential mechanisms for exacerbation of diabetic retinopathy by hypertension
I Suzuma et al.
DIABETES (2001)